We asked our analysts what findings from our physician studies really popped for them in 2017. Among the standouts: inbox overload prompting global pharma e-newsletter phatigue; an avalanche of stale details in the U.S.; and declining physician visits to pharma websites in the key emerging markets of China and Brazil.
Other content in this Stream
How to find your audience using social intelligence
How DRG Digital uses social data to help brands better understand their audiences and identify opportunities for engagement
Infographic:The Patient Switch Report: Understanding switching and adherence motivators
Demystifying Social Media - Understanding the Trends That Matter Most for Medical Publishers
Infographic: Supporting and educating patients in European markets
How can pharmaceutical firms communicate with patients in Germany, the UK, Spain, France and Italy?
Infographic: How effective is pharma outreach to EU physicians across channels?
A look at how effectively pharma companies are communicating with physicians in the EU5 (the UK, Germany, France, Spain and Italy) from our Taking the Pulse Europe study
Infographic: Docs doubt the power of healthcare's plan + PBM mergers
U.S. physicians are skeptical that mergers of PBMs, health plans and provider orgs can lower costs and improve care.
Healthcare's mega-merger-mania is catching. Docs are immune
Among the promises of mega-mergers like CVS-Aetna and Express Scripts-Cigna are lower costs for consumers and improved care through tech. Physicians -- especially older ones -- aren't buying it
Infographic: The 3 Digital HCP Trends you need to know
Infographic highlighting 3 digital HCP trends physician marketers should be aware of
How to build cred and better engagement with the busy U.S. physician
2018 physician research reveals how pharmaceutical brands can build trust with physicians via the sales force, remote detailing and better website content
Infographic: Pharma reps carry clout with physicians in Japan
Pharma company sales reps and websites are unusually influential with physicians in Japan, relative to other markets.
The three essential 'E's of the U.S. patient experience
The three areas of unmet need where pharma can play in bettering the U.S. patient experience: Empathy, empowerment, and expense.
Infographic: Amazon's move into distribution could impact adherence
Convenience is a factor for non-adherent patients, and that could factor into Amazon's drug distribution play.
1:20Patients want an Amazonian Experience from Pharma
Patients increasingly expect Amazon-style ease-of-use and personalization in their healthcare experience, too. Digital pharma veteran and head of Health Accelerators Joe Shields shares some insights i
Digital health news update: AI plays from Babylon, Samsung and AARP